Arena Pharmaceuticals, Inc. (ARNA) financial statements (2021 and earlier)

Company profile

Business Address 6154 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1,10474044627191156163
Cash and cash equivalents22024316115991156163
Short-term investments88449628588   
Other undisclosed cash, cash equivalents, and short-term investments   24   
Receivables 2522054
Inventory, net of allowances, customer advances and progress billings    71011
Inventory    71011
Contract with customer, asset  1
Disposal group, including discontinued operation   17   
Other undisclosed current assets35199(10)244
Total current assets:1,139760461281120175182
Noncurrent Assets
Property, plant and equipment22252330447283
Long-term investments and receivables 3718224   
Long-term investments 3718224   
Intangible assets, net (including goodwill)    288
Intangible assets, net (excluding goodwill)    288
Deposits noncurrent assets      1
Disposal group, including discontinued operation, noncurrent assets   1   
Other noncurrent assets2918104323
Deferred tax assets, net110    
Other undisclosed noncurrent assets   (1)  (1)
Total noncurrent assets:5141422658498294
TOTAL ASSETS:1,1911,174687339169257276
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities352516812810
Accounts payable12662623
Accrued liabilities5511113
Employee-related liabilities191495555
Derivative instruments and hedges, liabilities      0
Restructuring reserve    0  
Estimated litigation liability   24   
Disposal group, including discontinued operation   28   
Deferred revenue and credits1352115
Other undisclosed current liabilities23191412162041
Total current liabilities:58453072645067
Noncurrent Liabilities
Liabilities, other than long-term debt11121238893
Deferred revenue and credits128893
Other liabilities1112111  
Other undisclosed noncurrent liabilities4146495862  
Total noncurrent liabilities:52585160658893
Total liabilities:11010381132129138161
Stockholders' equity
Stockholders' equity attributable to parent1,0801,071606207405447
Common stock0000000
Additional paid in capital2,5872,1732,1071,6991,4421,4311,313
Accumulated other comprehensive income (loss)11(0)(1)(3)(1)3
Accumulated deficit(1,508)(1,103)(1,501)(1,490)(1,399)(1,376)(1,268)
Stockholders' equity attributable to noncontrolling interest    0  
Total stockholders' equity:1,0801,071606207405447
Other undisclosed liabilities and equity     6568
TOTAL LIABILITIES AND EQUITY:1,1911,174687339169257276

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues080618211243837
Revenue, net2720 
Cost of revenue (14)(1)(0)(14)(16)(6)
Cost of goods and services sold    (9)(9)(6)
Gross profit:079217211102231
Operating expenses(427)(309)(162)(113)(127)(126)(136)
Other undisclosed operating income      0
Operating income (loss):(427)483(145)(92)(17)(103)(105)
Nonoperating income (expense)22256(4)(6)(5)45
Investment income, nonoperating2427900050
Other nonoperating income (expense)233201(2)
Interest and debt expense(5)(5)(6)(6)(7)(7)(7)
Other undisclosed income from continuing operations before equity method investments, income taxes    777
Income (loss) from continuing operations before equity method investments, income taxes:(409)503(145)(102)(23)(108)(61)
Other undisclosed income from continuing operations before income taxes556    
Income (loss) from continuing operations before income taxes:(405)508(139)(102)(23)(108)(61)
Income tax expense (benefit) (110)110    
Other undisclosed income from continuing operations   6   
Income (loss) from continuing operations:(405)398(29)(96)(23)(108)(61)
Income (loss) from discontinued operations  (1)3   
Income (loss) before gain (loss) on sale of properties:(405)398(29)(93)(23)(108)(61)
Other undisclosed net loss    (0)  
Net income (loss):(405)398(29)(93)(23)(108)(61)
Net income attributable to noncontrolling interest   10  
Net income (loss) available to common stockholders, diluted:(405)398(29)(91)(23)(108)(61)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(405)398(29)(93)(23)(108)(61)
Other comprehensive income (loss)(1)1(0)    
Other undisclosed comprehensive income (loss) (0)02(2)  
Comprehensive income (loss):(405)399(29)(91)(25)(108)(61)
Comprehensive income, net of tax, attributable to noncontrolling interest   10  
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0    (4)(3)
Comprehensive income (loss), net of tax, attributable to parent:(405)399(29)(90)(24)(112)(63)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: